Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Phase II Study Evaluating the Efficacy, Safety, Tolerability and PK of siG12D-LODER in the Treatment of Patients With Unresectable LAPC When Used in Conjunction With Standard Chemotherapy (Gemcitabine+Nab-Paclitaxel) Versus Chemotherapy Alone

Summary

The purpose of this phase II study is to assess the response rate of siG12D-LODER with chemotherapy treatment (gemcitabine+nab-paclitaxel) in patients with unresectable, locally advanced pancreatic cancer.

For more information about the study, please visit: http://pancan-protact.com/

General Information

NCT#: NCT01676259
Study ID: SLSG12D-P2
Trial Phase: Phase II

Trial Sponsor: Silenseed Ltd.
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, siG12D-LODER™

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search